fbpx
Cyber-wellness Means Cyber-awareRead more Addressing maternal mental healthcare in AfricaRead more Qatar v. Ecuador to kick off FIFA World Cup 2022™ on 20 NovemberRead more Webb Fontaine Announces Launch of Niger National Single Window (NNSW) to Bolster TradeRead more Ethiopia: Loan from United Nations Fund Allows Food and Agriculture Organization (FAO) to Scale Up Fertilizers for Farmers in TigrayRead more How Choosing the Right Printer Helps Small Businesses and Content Creators to Save Time, Maximise Productivity and Achieve GrowthRead more Eritrea: World Breastfeeding WeekRead more Eritrean community festival in Scandinavian countriesRead more IOM: Uptick in Migrants Heading Home as World Rebounds from COVID-19Read more Network International & Infobip to offer WhatsApp for Business Banking Services to Financial Institution Clients across AfricaRead more

Pharma company seeks to make its birth control over-the-counter in US

show caption
Over-the-counter birth control, which could be made available at pharmacies in the US if HRA Pharma's application is successful, has long been backed by major medical organizations as a way to reduce barriers to contraception access./AFP
Print Friendly and PDF

Jul 12, 2022 - 09:37 AM

WASHINGTON — In a first, a pharmaceutical company applied Monday for US approval to make its birth control pill available over-the-counter, weeks after the US Supreme Court overturned a federal right to abortion care.

HRA Pharma, a subsidiary of Perrigo, said in a statement it was seeking the switch away from prescription-only for its product Opill, a progestin-only daily birth control pill — also referred to as a mini pill or non-estrogen pill.

Over-the-counter (OTC) birth control has long been backed by major medical organizations as a way to reduce barriers to contraception access.

The timing of the application — which comes amid a wave of state-level restrictions and bans on abortion following the top court’s ruling — was “coincidental,” according to an HRA spokeswoman, who said the company had been compiling research for its application for the past seven years.

“This historic application marks a groundbreaking moment in contraceptive access and reproductive equity in the US,” said Frederique Welgryn, chief strategic operations and innovation officer at HRA Pharma, in a statement.

“Moving a safe and effective prescription birth control pill to OTC will help even more women and people access contraception without facing unnecessary barriers.”

Over-the-counter birth control is backed by major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association and the American Academy of Family Physicians.

It is also standard practice in many countries, including Brazil, Greece, Mexico, Portugal, Russia, South Korea and Turkey.

Generally speaking, wealthier countries favor more regulations and thus prescription only birth control.

But according to ACOG, “Data support that progestin-only hormonal methods are generally safe and carry no or minimal risk of venous thromboembolism (VTE),” also known as blood clots.

“Several studies have demonstrated that women are capable of using self-screening tools to determine their eligibility for hormonal contraceptive use,” adds the organization, in an opinion on the matter published on its website.

A 2016 study found that nearly one third of US women who have tried to obtain prescription contraception reported access barriers.

The application will now be reviewed by the Food and Drug Administration, a process that would normally take around a year to complete.

LMBCNEWS.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.